Point-of-care coagulation testing
CoaguChek Pro II combines two tests in a single device
Read more
CoaguChek Pro II combines two tests in a single device
Read more
Carestream Health makes converting to DR easy and affordable with the launch of its CARESTREAM DRX-Transportable System/Lite. This system equips facilities to convert room-based or mobile imaging systems to DR through use of a wireless tablet PC that gives users complete control of the X-ray system and displays diagnostic images as they are acquired. Control from the wireless tablet eliminates the need to interface with a generator and use a cable connection, which delivers exceptional flexibility and saves both time and money. An access point in the detector communicates with the access point in the tablet to create a flexible solution that enhances workflow. The ability to quickly and easily convert CR systems to DR with the use of Carestream’s wireless tablet offers significant advantages for healthcare providers. The lightweight wireless tablet equips users to capture DR exams from any room-based or mobile imaging system while moving freely throughout the radiology department and the hospital. This system uses a virtual access point in the DRX detector to manage image capture and display images on the tablet. The tablet PC is self-powered and rechargeable. It has a 12-inch touch screen and weighs just 3.6 pounds (1.63 Kg). This new system is available in the United States, Canada, Europe and selected countries around the world.
Read more
Philips’ next generation interventional oncology solution OncoSuite enables physicians to provide analysis and minimally invasive, targeted treatment of tumour lesions reducing the impact to healthy tissue. It offers clinicians a better view of the treatment targets for informed decision making, while performing the procedure. While OncoSuite can be used for a number of different cancers including bone, kidney and lung, the system and its specific tools have been optimized for the treatment of patients with liver cancer. Given the steady increase in the prevalence of non-alcoholic fatty liver disease and liver cancer, the development and availability of new technology is much needed to provide interventional oncologists with a breakthrough that allows best possible treatment for these patients. What matters most in these cases, is the ability to visualize the liver tumours, even small ones, during the procedure and to approach them in a very targeted way to maximize the therapeutic outcome, while avoiding the destruction of healthy liver tissue. OncoSuite is designed to help physicians see, reach and treat liver cancer in a better way. OncoSuite enhances tumour embolization and ablation procedures with Philips’ interventional X-ray systems. It is the only platform in the industry that supports both procedures, enabling physicians to target multiple tumour lesions simultaneously. OncoSuite comprises the company’s innovative product offerings for enhanced imaging (XperCT Dual), live 3D image guidance for tumour embolization (EmboGuide) and live 3D image guidance for tumour ablation (XperGuide). Minimally invasive, image-guided interventional oncology procedures are a highly effective option for patients who cannot be treated through conventional techniques such as surgery, chemotherapy or radiation therapy. Interventional oncology procedures are rapidly increasing and OncoSuite provides the first complete interventional oncology portfolio for interventional radiologists, enabling physicians to see the entire tumour and its feeder vessels to directly target treatment avoiding healthy tissue. The innovative Open Trajectory function within XperCT Dual enables better centering of the liver with significantly improved visualization during the procedure of peripheral hepatic tumours in a single sweep. This feature provides a more targeted field of view making it possible to effectively scan larger patients. Previously, with the traditional geometric movement of the C-arm of the interventional X-ray system, part of the liver image was truncated and larger patients required multiple scans to visualize tumours in the periphery of the liver. Embolization procedures involve blocking the arteries feeding a tumour with beads to deprive it of nutrients and oxygen. They require the insertion of a catheter, which must be guided to the tumour site with the aid of live image-guidance. BTG (Biocompatibles UK Ltd) and Philips have been working in close collaboration on the visualization benefits of radio-opaque beads in combination with image-guided therapy. Together the companies have calibrated LC Bead LUMI and Philips Live Image Guidance Software to help interventional radiologists and multi-disciplinary teams to visualize better treatment options for patients with liver cancer. As a result, the next generation OncoSuite also features the world’s first optimized imaging for LC Bead LUMI that provides real-time visible confirmation of bead location during embolization procedures. In addition, the new Wiper Movement functionality improves workflow with automatic dual phase imaging, helping physicians to acquire two 3D cone beam CT datasets at different times of the procedure in a single step.
Read more
Hitachi Aloka has developed two different styles of diagnostic ultrasound systems to meet these needs. ARIETTA Precision supports surgical treatment and acute healthcare, while ARIETTA Prologue has been designed especially for the POC (Point of Care) ultrasound market where often new users are looking for ultrasound to provide better chronic and community healthcare. ARIETTA Precision has a slim profile with a large 21.5
Read more
The latest addition to the Stat Profile product line, Stat Profile Prime ES, has gained CE mark certification for release in CE regulated countries. Prime ES incorporates Nova Biomedical’s innovative no-maintenance sensor card technology for a smaller, faster, and less expensive electrolyte analyser. Compact and lightweight, Prime ES provides a comprehensive electrolyte profile including Na, K, Cl, iCa, and iMg in just 60 seconds from 50 microliters of whole blood. Stat Profi le Prime’s no-maintenance technology comprises a single MicroSensor Card that contains all sensors for Na, K, Cl, iCa, and iMg with a 32-day use life, and a reagent cartridge containing all calibration reagents. The MicroSensor Card and reagent cartridge are both maintenance free and easily replaced in seconds. This design optimizes the life of each, improves analyser uptime, and reduces costs. Credit card-sized, the MicroSensor Card is always calibrated and ready to deliver a stat electrolyte profile. Stat Profile Prime’s Clot Block sample flow path protects the MicroSensor Card from blockages and downtime caused by blood clots. A safety sample port aspirates samples directly from syringes, tubes, cups, and ampoules, eliminating sample transfer steps and saving time. Acceptable samples include whole blood, serum, plasma, urine, and cerebrospinal fluid. Simple to operate with a colour touchscreen and built-in barcode scanner for positive patient ID, Stat Profile Prime ES may be used in a fixed location virtually anywhere in a hospital/clinic or operated on a mobile cart with a battery back-up. An optional 10-sample removable tray provides serial batch testing for serum, plasma, and urine samples. Prime ES patient results can be easily interfaced to the LIS/HIS with the industry standard POCT 1-A2 connectivity format.
Read more
ZedScan is a portable, handheld device that uses patented Electrical Impedance Spectroscopy (EIS) to detect the development of pre-cancerous abnormalities of the cervix, known as cervical intraepithelial neoplasia (CIN). The innovative system not only removes subjectivity and increases accuracy, but it also helps clinicians manage growing colposcopy referrals generated by the introduction of primary HPV testing. In a recent review of over 1500 women referred to an NHS colposcopy clinic, the adoption of ZedScan resulted in a significant increase in disease detection and improvements in clinical performance. The patient case study revealed a 13% increase in detection of high-grade disease (HGCIN) across all patients, with 50% increase reported in women with low-grade cytology. In 92% of these cases, disease was confirmed with a single biopsy. If rolled out across the UK, this would equate to an additional 200 women being identified with HGCIN every week, or approximately 10,000 women each year who can therefore be diagnosed and treated much earlier. Thus preventing disease from developing. Performance was not impacted by the hrHPV genotype with increased detection in both HPV16 and non 16 hrHPV positive women. Cervical cancer is the 7th most common disease globally, and the third most prevalent in woman. The disease is caused by the persistent high-risk human papillomavirus (HPV) infection, which triggers changes in the cervical cells. Although colposcopy is an important method in detecting cervical cancer, in practice, the procedure has not drastically changed over the last 90 years, and diagnosis depends on the subjective assessment of visual indicators by the clinician. An objective assessment will help clinicians to better manage patients and help avoid unnecessary biopsies, treatments and repeat follow-up appointments.
To sharply focus on the specialized requirements in echocardiography, Toshiba engineers have built the new Aplio i900CV with a total redesign of hardware and software. The new Aplio i-series is a premium addition to the award-winning Aplio 500 platform, which is used in over 31,000 clinical settings to date. The system works very fast with a reduced requirement for user interaction, which translates into a significant time saving for the echocardiography lab.
The Aplio i-series features an architecture that gives it on-board capabilities for ultra-fast processing of advance applications, and with a new range of high frequency and ultra-wideband transducers. New with the Aplio i900CV is a 3-D transesophageal echocardiography (TEE) transducer that brings the possibility to view aortic leaflets, or to measure mitral valve parameters where it is possible not only to see the opening, but even also the stitches where the valve has been repaired. Yet, thanks to the new ultra-wideband transducers, a TEE exam is not always required. With the wider coverage and the extremely good penetration up to 28 centimetres, it is possible to evaluate the aortic valve area with a transthoracic approach. Clinicians are able to see distinctly four-chamber views, and have found excellent resolution in subcostal
views. Using a hybrid format in one display makes it possible to see calcified segments of coronary arteries derived from CT along with a quantification of the stenosis thanks to 3-D strain imaging, and at the same time a superimposition to the myocardium derived by CT. Using an innovative tool called Activation Imaging, it is possible to add measurements to determine torsion, an important parameter for a variety of diseases, or see areas where there is delayed contraction. Rest and stress, related to a specific coronary artery, can be seen as a superimposition on a CT image, enabling clinicians to make a decision as to intervention. At the heart of an enhanced image quality is the iBeam technology. Electrical dynamic focus with individual matrix element control and multiplexing with ultra-fast processing narrows and sharpens the signal for real-time 3-D beam forming. Advanced features include Superb Micro-Vascular Imaging (SMI) that combines the new transducers for more brilliant images with reduced motion artefacts, allowing extensive perfusion examination capabilities across all regions of human anatomy; Quad Fusion capability for interventional procedures or advanced diagnostics, with a simultaneous combination of CT/MRI images with real-time ultrasound and 3-D ultrasound rendering of a live procedure; super precise 3-D imaging boosted by Aplio i-series iBeam and thin slice acquisition to render near-photo quality images of anatomical structures.
Read more
The all-in-one QA-ES III Electrosurgical Analyzer helps ensure the functionality and safety of today’s modern, high-power electrosurgical units (ESU). Its user-friendly interface guides the user through test sequences, making it quick to collect all measurements, including vessel sealing, contact quality monitor (CQM), high frequency (HF) leakage, and output power distribution (single or continuous mode). Along with providing output power accuracy as low as +/-5% and built-in automation for easily performing power distribution tests, the QA-ES III offers intuitive, intelligent connectivity. Up to 5,000 records can be stored on-board, and then conveniently transferred to a PC wirelessly or via USB. Its Ansur test automation software makes it possible to create and automatically run tests, capture data, and produce reports. The QA-ES III complies with all global standards, including ANSI/AAMI and IEC.
Read more
The new IncuWarmer Babyleo TN500 offers optimal thermoregulation in open care, closed care and transition. The device provides a stable micro-environment for the premature baby and is also very quiet, typically operating at 40 dB(A). The wide-ranged height adjustment function, jumbo hand ports and an easy-to-open hood allow clinicians and parents to comfortably and efficiently provide care to the premature baby. An integrated audio system and kangaroo mode help actively involve the parents in caring for their child. The Babyleo IncuWarmer enables open and closed care in a single device and provides superior thermoregulation via three synchronized heat sources to ensure the temperature is maintained even when the hood is opened. A constant supply of warmth is especially criticial for the healthy development of the premature baby. In addition, the device has an automatic humidifier so the humidity level is automatically adjusted according to the temperature settings. When humidity levels are high, to avoid condensation build up on the hood of the device, a Clear View feature activates the radiant warmer to ensure the care team always has good visibility. To make care rounds more comfortable for the staff and parents, Babyleo has a wide variable height range that allows sitting or standing, and makes it easy to find the right position to access the baby. Additionally, the jumbo hand ports, generous storage space and a bed coupling system for the Drager Babylog VN500 ventilator facilitate workflows. Babyleo supports kangaroo care, a technique where the infant is held on a parent’s chest. The kangaroo mode ensures the baby is monitored during skin-to-skin care and that Babyleo’s settings remain set for the baby’s return. It is the first device to also include an audio function which allows, for example, mothers to play music or recorded voice files for their babies via an MP3 player plugged into the side of the device. A small loudspeaker delivers the recording inside the device at a low, controlled volume. Furthermore, Babyleo has a Family View screen. The user interface of the screen displays a select number of easy-to-read medical parameter values, in an effort to reduce parent anxiety, and also includes the baby’s name and a personalized icon so each device is individualized. Parents and caregivers can also choose between seven different mood light colours to gently light the floor area and create a nice atmosphere.
Read more
Siemens Healthineers has launched a range of new MR applications to help hospitals reduce the time needed for MR imaging within neurology. It is estimated that 20 to 25 per cent of all MR examinations are neurological, with the number expected to grow in 2016. The applications have therefore been designed to help organizations increase patient throughput in order to maintain an efficient workflow. One of the applications, Simultaneous Multi-Slice (SMS) EPI, employs an innovative technique to acquire imaging slices simultaneously rather than sequentially, reducing 2D acquisition times with acceleration factors up to eight. Simultaneous Multi-Slice (SMS) EPI can bring DTI and BOLD into clinical routine. This can particularly benefit surgical neurology cases through surgical mapping, potentially helping to reduce post-surgical deficits, and ultimately leading to improved efficiency in the utilization of operating room resources. A further application, GOBrain, enables clinically validated brain examinations in just five minutes. Facilitated in part by Siemens’ high-channel density coils and DotGO software, clinically essential image orientations and all relevant contrasts can be acquired rapidly. In turn, this can improve patient throughput, and costs per scan can potentially be reduced. Shorter scan times can also be better tolerated by patients, and can help reduce the need of sedations and rescans, which can be time-consuming and costly. It is paramount that imaging techniques used to assess neurological conditions continue to advance at a fast pace, as diseases such as dementia are on the rise. There is an increase in demand for diagnostic imaging within neurology, and a priority is to ensure patients receive their tests within the recommended turnaround time. In addition to speed and quality, standardization across systems is also an important element for hospitals when it comes to meeting healthcare efficiency demands. The recently introduced syngo MR E11 software platform is a uniform application platform for the MAGNETOM family and the Biograph mMR MR-Pet system. The focus, in addition to expanding the application offering, is achieving consistency across the entire fleet of systems and managing these effectively. This and other planned improvements show the potential of the Biograph mMR, as it utilizes the MR information to improve PET beyond its current capabilities. The BodyCOMPASS application is designed to enable motion-free PET images with MR-based motion compensation beyond gating, which could be particularly beneficial in delineating abdominal and lung lesions.
Read more
April 2024
The medical devices information portal connecting healthcare professionals to global vendors
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyCookie settingsWe may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Privacy policy